International medical imaging IT and cybersecurity company Sectra has signed a ten-year contract with Isala Hospital, in the Netherlands. The contract comprises Sectra’s information technology (IT) solution for reviewing diagnostic images. The solution enables physicians at Isala Hospital to access and review medical images from any of its two hospitals, regardless of where current and prior images were taken. The joint solution also enables the two sites to efficiently share resources.

Noninvasive computed tomography (CT) angiography and stress tests can help predict which patients are likely to suffer a heart attack or other adverse cardiovascular event, according to a new study appearing online in the journal Radiology.

Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new solutions for biopsy workflow, at the European Congress of Radiology (ECR) in Vienna, Austria, March 1-5. The company also hosted a symposium and several educational workshops throughout the show, giving attendees opportunities to experience screening and interventional products that offer unique patient and user benefits and address workflow challenges.

Stratasys Ltd. announced last week enrollment is now open for 3DHEART, an investigator-initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3-D-printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new recommendations on procedures employing gadolinium-based contrast agents, in which the committee recommended suspension of marketing authorization for four agents.

March 10, 2017 — New research published in The American Journal of Medicine reveals patient-centered educational ...

The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some patients, however, the contrast agents used in this process can cause health problems. A team at the Technical University of Munich (TUM) has now demonstrated that the required quantity of these substances can be significantly reduced if monoenergetic X-rays from a miniature particle accelerator are used.

Carestream will demonstrate its OnSight 3-D Extremity System that uses cone beam computed tomography (CBCT) technology to capture high-quality, low-dose 3-D extremity exams at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting and exhibit, March 14-18 in San Diego.